Kimia Biosciences Q2 Results FY27: PAT Jumps 134.31% to Rs 2.39 Cr, Revenue Rs 26.81 Cr

Kimia Biosciences Ltd (KIMIABL) Q2 Results FY27 announced on 13 November 2026, covering the company's financial performance for the July to September quarter. The company reported Standalone results with revenue of Rs 26.81 Cr and PAT of Rs 2.39 Cr. The results date of 13 November 2026 anchors every comparison below, and Kimia Biosciences Q2 Results FY27 show revenue lower but profit higher than a year earlier.

This Kimia Biosciences Q2 Results analysis covers the financial highlights, the business factors disclosed with the numbers, the FY27 outlook and the risks to watch. Readers who track results on the Univest Screener will find this results analysis organised in that order, beginning with the Financial Highlights table that follows.

Click Here – Get Free Investment Predictions

Kimia Biosciences Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 26.81 Cr	Rs 34 Cr	-21.15% YoY
Operating Profit	Rs 4.58 Cr	Rs 2.52 Cr	+81.75% YoY
Net Profit (PAT)	Rs 2.39 Cr	Rs 1.02 Cr	+134.31% YoY

Source: company filing for Kimia Biosciences Q2 Results FY27, 13 November 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Kimia Biosciences Q2 Results: What Stands Out

• Revenue: Rs 26.81 Cr against Rs 34.00 Cr in the same quarter last year, a YoY decline of 21.15% in the standalone results for July to September 2026.
• Net profit: Rs 2.39 Cr against Rs 1.02 Cr a year earlier, a rise of 134.31%, so net profit moved in the opposite direction to revenue.
• Operating Profit: Rs 4.58 Cr against Rs 2.52 Cr, up 81.75% YoY, which is a smaller percentage rise than the one in net profit.
• Net margin: net profit was 8.9% of revenue against 3.0% in the comparison quarter, a gap that Kimia Biosciences Q2 Results FY27 make visible at once.
• Returns: return on equity of 53.70% and return on capital employed of 25.24% in FY26 sit beside these YoY growth figures in the performance analysis below.

Kimia Biosciences Q2 Results FY27: Performance Analysis

Kimia Biosciences Q2 Results FY27 show revenue of Rs 26.81 Cr, Operating Profit of Rs 4.58 Cr and net profit of Rs 2.39 Cr. The YoY growth figures are negative at 21.15% for revenue, but positive at 81.75% for Operating Profit and 134.31% for net profit on a standalone basis.

In rupee terms, revenue was lower by Rs 7.19 Cr, while Operating Profit was higher by Rs 2.06 Cr and net profit by Rs 1.37 Cr against the year-earlier quarter. This results analysis shows that profit rose even as sales fell, which is the pattern a reader of Kimia Biosciences Q2 Results meets first.

Operating Profit was 17.08% of revenue against 7.41% a year earlier, while net profit was 8.91% of revenue against 3.00%. The quarterly results therefore record a higher margin at both profit lines, and Kimia Biosciences Q2 Results FY27 place the largest YoY rise at net profit. That leads the results analysis to the business factors disclosed alongside the numbers.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Net Profit Growth – The results analysis begins with net profit, which rose 134.3% year on year to Rs 2.39 Cr. In Kimia Biosciences Q2 Results FY27, this is the largest percentage move among the three reported lines.

Net Profit Margin – Net profit margin improved to 8.9% from 3.0% in the comparison quarter. The margin is the disclosed factor that connects lower revenue with higher profit in the quarterly results.

Return Ratios – Return on equity was 53.70% in FY26 and return on capital employed was 25.24% in FY26. These ratios describe how the company earned on its equity and capital base, as disclosed with the results.

FY27 Outlook After Kimia Biosciences Q2 Results

Full-year FY27 results will depend on the quarters that follow and on the conditions the company discloses over the coming months. The July to September quarter, reported on the results date of 13 November 2026, is one data point in that sequence, and a results analysis of one quarter cannot fix the path of the year.

Investors following Kimia Biosciences Q2 Results FY27 can place the Rs 2.39 Cr net profit beside the next quarterly filing and see whether the YoY rise of 134.31% holds or narrows. Univest users can follow that comparison on the Univest app as each new filing arrives, and the risks below set out what deserves the closest attention.

Key Risks to Watch After Kimia Biosciences Q2 Results FY27

Revenue Decline

Revenue declined 21.1% year on year to Rs 26.81 Cr in the latest quarter. Because every profit line starts from revenue, the size of this decline is the first figure to compare when the next quarterly results are filed.

High Debt Level

Debt is high at 1.95 times total assets in FY26. Together with the 134.31% rise in net profit, this debt level is why Kimia Biosciences Q2 Results FY27 deserve a second look at the balance sheet.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 0.36 Cr to Rs 5.44 Cr over the last 5 quarters. A range this wide means YoY growth in any single quarter should be read beside the quarters around it.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Kimia Biosciences Q2 Results FY27 show a standalone quarter in which revenue fell 21.15% to Rs 26.81 Cr while net profit rose 134.31% to Rs 2.39 Cr. Operating Profit was up 81.75%, a smaller rise than net profit. Measured from the results date, these quarterly results are best read beside the improved net margin and the debt level. Investors should consult a SEBI-registered advisor before acting, and Kimia Biosciences Q2 Results is a record of figures, not advice.

Frequently Asked Questions on Kimia Biosciences Q2 Results FY27

What are Kimia Biosciences Q2 Results FY27?

Ans. Kimia Biosciences Q2 Results FY27 cover the July to September 2026 quarter and were declared on 13 November 2026. Alongside this, revenue was Rs 26.81 Cr and net profit Rs 2.39 Cr, as the Financial Highlights table shows.

What is the results date for Kimia Biosciences Q2 Results FY27?

Ans. The results date for Kimia Biosciences Q2 Results FY27 is 13 November 2026, when the company declared its July to September numbers. This is the date used in the Quick Answer and in the opening paragraphs of the analysis.

What revenue was reported in Kimia Biosciences Q2 Results FY27?

Ans. Kimia Biosciences reported Q2 FY27 revenue of Rs 26.81 Cr, compared with Rs 34.00 Cr a year earlier, so revenue was lower by Rs 7.19 Cr, as the Performance Analysis section shows.

What net profit was reported in Kimia Biosciences Q2 Results FY27?

Ans. Net profit in Kimia Biosciences Q2 Results FY27 was Rs 2.39 Cr against Rs 1.02 Cr a year earlier, which means net profit was higher by Rs 1.37 Cr, as the Key Takeaways section notes.

How much YoY growth did revenue show in Kimia Biosciences Q2 Results FY27?

Ans. Revenue declined 21.15% YoY in Kimia Biosciences Q2 Results FY27, from Rs 34.00 Cr to Rs 26.81 Cr, while net profit grew 134.31%, as the Performance Analysis section sets out in detail.

Did net profit rise or fall in Kimia Biosciences Q2 Results?

Ans. Net profit rose in Kimia Biosciences Q2 Results, from Rs 1.02 Cr to Rs 2.39 Cr, a YoY rise of 134.31%, so it moved against the revenue decline covered in the Key Takeaways section.

What was the Operating Profit in Kimia Biosciences Q2 Results FY27?

Ans. Operating Profit in Kimia Biosciences Q2 Results FY27 was Rs 4.58 Cr against Rs 2.52 Cr, up 81.75% YoY, which means it rose by less than net profit, as the Performance Analysis section explains.

Are Kimia Biosciences Q2 Results consolidated results or standalone results?

Ans. Kimia Biosciences Q2 Results are standalone results, so the company's figures are reported on a standalone basis. This basis applies to every number in the Financial Highlights table and in the sections of this article.

What business factors shaped Kimia Biosciences Q2 Results FY27?

Ans. Kimia Biosciences Q2 Results FY27 come with disclosed factors including 134.3% net profit growth, a net margin of 8.9% and return on equity of 53.70%, as the Key Business Factors section describes.

What are the key risks after Kimia Biosciences Q2 Results FY27?

Ans. The key risks after Kimia Biosciences Q2 Results FY27 are the 21.1% revenue decline, debt at 1.95 times total assets and volatile quarterly net profit, which the Key Risks section lists in order.

What is the outlook after Kimia Biosciences Q2 Results?

Ans. Full-year FY27 results after Kimia Biosciences Q2 Results will depend on the quarters that follow, so this quarter alone does not set the year. Alongside this, the Outlook section suggests tracking the next filing.

Where can I find the complete Kimia Biosciences Q2 Results FY27 data?

Ans. The complete Kimia Biosciences Q2 Results FY27 data sits in the Financial Highlights table above and on the Univest Screener, which carries the standalone results for the quarter and the YoY comparison.